 | • レポートコード：D0804-16790 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、トキソプラズマ症診断検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。トキソプラズマ症診断検査の種類別市場規模（間接免疫蛍光試験（IFAT）、修正凝集試験（MAT）、酵素免疫測定法（ELISA）、免疫グロブリン試験）、用途別市場規模（病院、クリニック、診断研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Danaher、Thermo Fisher Scientific、GenBio、Bio-Rad、Biotest、Biomerica ・地域別グローバル市場分析 2015年-2020年 ・トキソプラズマ症診断検査の北米市場（アメリカ、カナダ、メキシコ） ・トキソプラズマ症診断検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・トキソプラズマ症診断検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・トキソプラズマ症診断検査の南米市場（ブラジル、アルゼンチン） ・トキソプラズマ症診断検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：間接免疫蛍光試験（IFAT）、修正凝集試験（MAT）、酵素免疫測定法（ELISA）、免疫グロブリン試験 ・用途別分析：病院、クリニック、診断研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Toxoplasmosis Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Toxoplasmosis Diagnostic Testing sales will be xx in 2020 from Toxoplasmosis Diagnostic Testing million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Toxoplasmosis Diagnostic Testing market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Toxoplasmosis Diagnostic Testing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Toxoplasmosis Diagnostic Testing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Toxoplasmosis Diagnostic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Toxoplasmosis Diagnostic Testing market has been segmented into:
Indirect Immune Fluorescent Test (IFAT)
Modified Agglutination Test (MAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoglobulin Tests
By Application, Toxoplasmosis Diagnostic Testing has been segmented into:
Hospitals
Clinics
Diagnostic Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Toxoplasmosis Diagnostic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Toxoplasmosis Diagnostic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Toxoplasmosis Diagnostic Testing market.
The report offers in-depth assessment of the growth and other aspects of the Toxoplasmosis Diagnostic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Toxoplasmosis Diagnostic Testing Market Share Analysis
Toxoplasmosis Diagnostic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Toxoplasmosis Diagnostic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Toxoplasmosis Diagnostic Testing sales, revenue and market share for each player covered in this report.
The major players covered in Toxoplasmosis Diagnostic Testing are:
Abbott
Danaher
Thermo Fisher Scientific
GenBio
Bio-Rad
Biotest
Biomerica
1 Toxoplasmosis Diagnostic Testing Market Overview
1.1 Product Overview and Scope of Toxoplasmosis Diagnostic Testing
1.2 Classification of Toxoplasmosis Diagnostic Testing by Type
1.2.1 Global Toxoplasmosis Diagnostic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type in 2019
1.2.3 Indirect Immune Fluorescent Test (IFAT)
1.2.4 Modified Agglutination Test (MAT)
1.2.5 Enzyme-Linked Immunosorbent Assay (ELISA)
1.2.6 Immunoglobulin Tests
1.3 Global Toxoplasmosis Diagnostic Testing Market by End Users
1.3.1 Overview: Global Toxoplasmosis Diagnostic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Global Toxoplasmosis Diagnostic Testing Market by Regions
1.4.1 Global Toxoplasmosis Diagnostic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Toxoplasmosis Diagnostic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Toxoplasmosis Diagnostic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Toxoplasmosis Diagnostic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Toxoplasmosis Diagnostic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Toxoplasmosis Diagnostic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Toxoplasmosis Diagnostic Testing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Toxoplasmosis Diagnostic Testing Industry Impact
1.5.1 COVID-19 Potential Implications for the Toxoplasmosis Diagnostic Testing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Toxoplasmosis Diagnostic Testing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Danaher SWOT Analysis
2.2.4 Danaher Product and Services
2.2.5 Danaher Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Thermo Fisher Scientific SWOT Analysis
2.3.4 Thermo Fisher Scientific Product and Services
2.3.5 Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 GenBio
2.4.1 GenBio Details
2.4.2 GenBio Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GenBio SWOT Analysis
2.4.4 GenBio Product and Services
2.4.5 GenBio Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Rad SWOT Analysis
2.5.4 Bio-Rad Product and Services
2.5.5 Bio-Rad Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biotest
2.6.1 Biotest Details
2.6.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biotest SWOT Analysis
2.6.4 Biotest Product and Services
2.6.5 Biotest Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biomerica
2.7.1 Biomerica Details
2.7.2 Biomerica Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biomerica SWOT Analysis
2.7.4 Biomerica Product and Services
2.7.5 Biomerica Toxoplasmosis Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Toxoplasmosis Diagnostic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Toxoplasmosis Diagnostic Testing Players Market Share
3.2.2 Top 10 Toxoplasmosis Diagnostic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Toxoplasmosis Diagnostic Testing Revenue and Market Share by Regions
4.2 North America Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
5 North America Toxoplasmosis Diagnostic Testing Revenue by Countries
5.1 North America Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
5.2 USA Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
6 Europe Toxoplasmosis Diagnostic Testing Revenue by Countries
6.1 Europe Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
6.2 Germany Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.4 France Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue by Countries
7.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
7.2 China Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.5 India Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
8 South America Toxoplasmosis Diagnostic Testing Revenue by Countries
8.1 South America Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
8.2 Brazil Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Toxoplasmosis Diagnostic Testing by Countries
9.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Toxoplasmosis Diagnostic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Toxoplasmosis Diagnostic Testing Market Forecast by Type (2019-2024)
10.3 Indirect Immune Fluorescent Test (IFAT) Revenue Growth Rate (2015-2025)
10.4 Modified Agglutination Test (MAT) Revenue Growth Rate (2015-2025)
10.5 Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Growth Rate (2015-2025)
10.6 Immunoglobulin Tests Revenue Growth Rate (2015-2025)
11 Global Toxoplasmosis Diagnostic Testing Market Segment by End Users
11.1 Global Toxoplasmosis Diagnostic Testing Revenue Market Share by End Users (2015-2020)
11.2 Toxoplasmosis Diagnostic Testing Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Diagnostic Laboratories Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Toxoplasmosis Diagnostic Testing Market Size Forecast (2021-2025)
12.1 Global Toxoplasmosis Diagnostic Testing Market Size Forecast (2021-2025)
12.2 Global Toxoplasmosis Diagnostic Testing Market Forecast by Regions (2021-2025)
12.3 North America Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
12.6 South America Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Toxoplasmosis Diagnostic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Toxoplasmosis Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Toxoplasmosis Diagnostic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Toxoplasmosis Diagnostic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Toxoplasmosis Diagnostic Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Corporate Information, Location and Competitors
Table 7. Abbott Toxoplasmosis Diagnostic Testing Major Business
Table 8. Abbott Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 9. Abbott SWOT Analysis
Table 10. Abbott Toxoplasmosis Diagnostic Testing Product and Solutions
Table 11. Abbott Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Danaher Corporate Information, Location and Competitors
Table 13. Danaher Toxoplasmosis Diagnostic Testing Major Business
Table 14. Danaher Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2018-2019)
Table 15. Danaher SWOT Analysis
Table 16. Danaher Toxoplasmosis Diagnostic Testing Product and Solutions
Table 17. Danaher Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 19. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Major Business
Table 20. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 21. Thermo Fisher Scientific SWOT Analysis
Table 22. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Product and Solutions
Table 23. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. GenBio Corporate Information, Location and Competitors
Table 25. GenBio Toxoplasmosis Diagnostic Testing Major Business
Table 26. GenBio Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 27. GenBio SWOT Analysis
Table 28. GenBio Toxoplasmosis Diagnostic Testing Product and Solutions
Table 29. GenBio Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Bio-Rad Corporate Information, Location and Competitors
Table 31. Bio-Rad Toxoplasmosis Diagnostic Testing Major Business
Table 32. Bio-Rad Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 33. Bio-Rad SWOT Analysis
Table 34. Bio-Rad Toxoplasmosis Diagnostic Testing Product and Solutions
Table 35. Bio-Rad Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Biotest Corporate Information, Location and Competitors
Table 37. Biotest Toxoplasmosis Diagnostic Testing Major Business
Table 38. Biotest Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 39. Biotest SWOT Analysis
Table 40. Biotest Toxoplasmosis Diagnostic Testing Product and Solutions
Table 41. Biotest Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Biomerica Corporate Information, Location and Competitors
Table 43. Biomerica Toxoplasmosis Diagnostic Testing Major Business
Table 44. Biomerica Toxoplasmosis Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 45. Biomerica SWOT Analysis
Table 46. Biomerica Toxoplasmosis Diagnostic Testing Product and Solutions
Table 47. Biomerica Toxoplasmosis Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) by Players (2015-2020)
Table 49. Global Toxoplasmosis Diagnostic Testing Revenue Share by Players (2015-2020)
Table 50. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) by Regions (2015-2020)
Table 51. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Regions (2015-2020)
Table 52. North America Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
Table 53. North America Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Table 54. Europe Toxoplasmosis Diagnostic Testing Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue (Million USD) by Countries (2015-2020)
Table 56. South America Toxoplasmosis Diagnostic Testing Revenue by Countries (2015-2020)
Table 57. South America Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Table 60. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) by Type (2015-2020)
Table 61. Global Toxoplasmosis Diagnostic Testing Revenue Share by Type (2015-2020)
Table 62. Global Toxoplasmosis Diagnostic Testing Revenue Forecast by Type (2021-2025)
Table 63. Global Toxoplasmosis Diagnostic Testing Revenue by Application (2015-2020)
Table 64. Global Toxoplasmosis Diagnostic Testing Revenue Share by Application (2015-2020)
Table 65. Global Toxoplasmosis Diagnostic Testing Revenue Forecast by Application (2021-2025)
Table 66. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Toxoplasmosis Diagnostic Testing Picture
Figure 2. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type in 2019
Figure 3. Indirect Immune Fluorescent Test (IFAT) Picture
Figure 4. Modified Agglutination Test (MAT) Picture
Figure 5. Enzyme-Linked Immunosorbent Assay (ELISA) Picture
Figure 6. Immunoglobulin Tests Picture
Figure 7. Toxoplasmosis Diagnostic Testing Revenue Market Share by End Users in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Toxoplasmosis Diagnostic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Toxoplasmosis Diagnostic Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Toxoplasmosis Diagnostic Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players Toxoplasmosis Diagnostic Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Regions in 2018
Figure 26. North America Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 33. USA Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 38. Germany Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 40. France Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 45. China Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 48. India Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Toxoplasmosis Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global Toxoplasmosis Diagnostic Testing Revenue Share by Type (2015-2020)
Figure 61. Global Toxoplasmosis Diagnostic Testing Revenue Share by Type in 2019
Figure 62. Global Toxoplasmosis Diagnostic Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global Indirect Immune Fluorescent Test (IFAT) Revenue Growth Rate (2015-2020)
Figure 64. Global Modified Agglutination Test (MAT) Revenue Growth Rate (2015-2020)
Figure 65. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Growth Rate (2015-2020)
Figure 66. Global Immunoglobulin Tests Revenue Growth Rate (2015-2020)
Figure 67. Global Toxoplasmosis Diagnostic Testing Revenue Share by Application (2015-2020)
Figure 68. Global Toxoplasmosis Diagnostic Testing Revenue Share by Application in 2019
Figure 69. Global Toxoplasmosis Diagnostic Testing Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Clinics Revenue Growth Rate (2015-2020)
Figure 72. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Toxoplasmosis Diagnostic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Toxoplasmosis Diagnostic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 80. South America Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Toxoplasmosis Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
ウイルス検査診断キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Virus Testing Diagnostic Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Virus Testing D…- アレルギー診断テストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Allergy Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 子宮頸がん診断検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 8198.9 million by 2025, from USD 6937.9 million in 2019. The C…
- 子宮頸がん診断検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 8198.9 million by 2025, from USD 6937.9 million in 2019. The C…
- 脳卒中検査バイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Stroke Testing Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stroke Testing Biom…